first large study of glp-1 receptor agonists during pregnancy Taking GLP-1s the trimester does not appear to substantially increase the risk of adverse outcomes glp-1 pregnancy safety news today
Description
The next wave will define it
Your physician can submit this history as part of the prior authorization to significantly strengthen the approval case
GLP-1R agonists present a promising therapeutic option for HFpEF by targeting endothelial dysfunction and other pathophysiological mechanisms
Vara E, Arias-Daz J, Garcia C, Balibrea JL, Blzquez E
[DOI] [PubMed] [Google Scholar] 148.Bendotti G., et al
